PolyPid to Present Its Positive Phase 3 SHIELD II Topline Results at the 2025 American College of Surgeons Clinical Congress

Stock Information for PolyPid Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About PolyPid Ltd.

PolyPid Announces Positive FDA Pre-NDA Meeting Minutes for D-PLEX??? Supporting NDA Submission
PolyPid to Participate in ROTH Capital Partners Virtual KOL Event on December 10, 2025
PolyPid Provides Corporate Update and Reports Third Quarter 2025 Financial Results
PolyPid's D-PLEX??? Wins BioTech Breakthrough Award for "Therapeutics Solution of the Year"
PolyPid to Report Third Quarter 2025 Financial Results and Operational Highlights on November 12, 2025
PolyPid to Present at Lytham Partners Fall 2025 Investor Conference and Participate in 4th Annual ROTH Healthcare Opportunities Conference
PolyPid Successfully Completes Israeli Ministry of Health GMP Inspection, Advancing Towards Commercial Manufacturing Readiness for D-PLEX???
PolyPid to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.